08:00 , Jan 13, 2014 |  BC Week In Review  |  Company News

Amneal Pharmaceuticals, Hanmi Pharmaceutical, AstraZeneca sales and marketing update

Amneal launched in the U.S. an authorized generic of AstraZeneca's gastrointestinal drug Nexium esomeprazole strontium delayed-release capsules. Amneal said it cannot comment on pricing because the company sells esomeprazole strontium delayed-release capsules through wholesalers. Late...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

Hanmi Pharmaceutical, AstraZeneca generics, gastrointestinal news

The U.S. Court of Appeals for the Federal Circuit ruled that Hanmi's generic version of AstraZeneca's Nexium esomeprazole does not infringe on the pharma's U.S. Patent No. 5,714,504. On Dec. 17, 2013, Amneal Pharmaceuticals LLC...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Company News

Hanmi Pharmaceutical, AstraZeneca generics, gastrointestinal news

The U.S. Court of Appeals for the Federal Circuit lifted a temporary injunction that enjoined Hanmi from launching its generic version of AstraZeneca's Nexium esomeprazole in the U.S., which means Hanmi is now free to...
07:00 , Sep 23, 2013 |  BC Week In Review  |  Company News

Hanmi Pharmaceutical, AstraZeneca generics, gastrointestinal news

The U.S. Court of Appeals for the Federal Circuit temporarily enjoined Hanmi from launching its generic version of AstraZeneca's Nexium esomeprazole in the U.S. pending resolution of an appeal by the pharma. The court directed...
07:00 , Jun 17, 2013 |  BC Week In Review  |  Company News

Amneal Pharmaceuticals, Hanmi Pharmaceutical, AstraZeneca generics, gastrointestinal news

The companies entered into a consent judgment to resolve aspects of ongoing litigation regarding two patents covering Nexium esomeprazole from AstraZeneca. Under the terms of the consent judgment, Amneal and Hanmi have conceded the validity...
08:00 , Feb 4, 2013 |  BC Week In Review  |  Company News

Amneal Pharmaceuticals, Hanmi Pharmaceutical deal

Amneal acquired exclusive distribution rights to Hanmi's NDA for esomeprazole strontium delayed-release capsules, which is under FDA review. The PDUFA date is April 29. The product is a generic version of Nexium from AstraZeneca plc...